GILBERT'S LLP for MYLAN LABORATORIES INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Feb 9, 2009 | $90,000 | Replaced |
| 4th Quarter - Amendment | Oct 23, 2009 | $90,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAWEL BAILEY | — |
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
Consumer Issues/Safety/Products CSP
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAWEL BAILEY | — |
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
Pharmacy PHA
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAWEL BAILEY | — |
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.